Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Income investors have liked Pfizer (NYSE: PFE) for years. However, the big drugmaker's exceptionally juicy dividend these ...

So, is Pfizer's 7.63% dividend yield worth the effort? If I base my decision solely on a first level analysis of its past, I would say NO. Yet, investment is always about the future, not the past ...

How many shares of Pfizer should you own to make $10,000 in annual dividend income? Where to invest $1,000 right now? Our ...

The company started demonstrating FCF recovery over the last few quarters and in the above analysis ... in PFE prior to the upcoming earnings release. A 7.5% forward dividend yield is absolutely ...

We recently published a list of the 15 Best High-Yield Dividend Stocks for 2025 and Beyond. In this article, we are going to take a look at where Pfizer Inc. (NYSE:PFE) stands against other best ...

Of the 22 guru strategies we follow, PFE rates highest using our Shareholder Yield Investor model based on the published strategy of Meb Faber. This strategy looks for companies returning cash to ...

As of April 20, the stock has a dividend yield of 7.77%. Overall, PFE ranks 1st on our list of the safe dividend stocks with yields over 5%. While we acknowledge the potential of PFE as an ...

Trading for $23.03, PFE stock is down 13.5% year-to-date and 17% in 12 months. It has a dividend yield of 7.47%, which makes it worth an addition to your portfolio. It has increased dividends for ...

But I wouldn't bet on the drugmaker's dividend yield remaining as high as it is now. A lot of negativity is baked into Pfizer's share price, with the stock trading at less than 8 times forward ...

PFE) for years. However, the big drugmaker's exceptionally juicy dividend these days has made its stock even more attractive. But when a dividend yield reaches ultrahigh levels, investors can feel ...